SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
crystal
Lv3
245 积分
2022-04-12 加入
最近求助
最近应助
互助留言
Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy
3天前
已完结
P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy
8天前
已完结
Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives
8天前
已关闭
Improved Post remission survival of non- favorable risk Acute Myelogenous Leukemia (AML) patients following initial remission induction therapy with FLAG+/-Idarubicin versus 3 + 7 (Anthracycline + Cytarabine)
8天前
已完结
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
10天前
已完结
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow‐up from a phase 1b study
12天前
已完结
Metabolic regulation of chemoresistance and immuno-surveillance in AML by SHP-1
13天前
已完结
SHP1 regulates a STAT6–ITGB3 axis in FLT3ITD-positive AML cells
13天前
已完结
The functions and regulation of the PTEN tumour suppressor: new modes and prospects
14天前
已完结
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
15天前
已完结
没有进行任何应助
感谢,点赞
3天前
速度真快
8天前
帮大忙了
10天前
感谢,帮大忙了
12天前
感谢,速度真快
13天前
感谢,帮大忙了
13天前
点赞,帮大忙了
15天前
感谢,速度真快
16天前
感谢,速度真快
16天前
感谢,速度真快
16天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论